As of 2025-07-03, the Intrinsic Value of SCYNEXIS Inc (SCYX) is (2.14) USD. This SCYX valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 0.72 USD, the upside of SCYNEXIS Inc is -396.8%.

The range of the Intrinsic Value is (9.23) - (1.22) USD.

Is SCYX undervalued or overvalued?

Based on its market price of 0.72 USD and our intrinsic valuation, SCYNEXIS Inc (SCYX) is overvalued by 396.8%.

Note: result may not be accurate due to the invalid valuation result of DCF model.

0.72 USD

Stock Price

(2.14) USD

Intrinsic Value

Intrinsic Value Details

SCYX Intrinsic Value - Valuation Summary

	Range	Selected	Upside
a
DCF (Growth Exit 5Y)	(9.23) - (1.22)	(2.14)	-396.8%
Peter Lynch Fair Value	-3.47 - -3.47	-3.47	-582.06%
P/E Multiples	(12.84) - (12.79)	(13.07)	-1914.9%
EV/EBITDA Multiples	(5.91) - (5.82)	(6.69)	-1029.3%

SCYX Intrinsic Value - Peers Comparison

	Range	Selected	Upside
a
Eli Lilly and Co	309.55 - 1,638.55	525.75	-32.5%
Johnson & Johnson	105.29 - 322.2	158.75	2.1%
Merck & Co Inc	97.49 - 155.2	119.79	45.4%
Pfizer Inc	20.82 - 75.19	34.62	36.7%
Bristol-Myers Squibb Co	13.31 - 13.31	13.31	-72%
Zoetis Inc	126.52 - 606.65	209.09	31.4%
Royalty Pharma PLC	19.89 - 140.12	39.21	8.3%
Elanco Animal Health Inc	11.61 - 20.48	15.15	2.9%
Next Green Wave Holdings Inc	0.72 - 1.15	0.96	133.0%

SCYX Intrinsic Value - Key Valuation Metrics

Market Cap (mil)	28
Beta	1.21
Outstanding shares (mil)	39
Enterprise Value (mil)	21

Market risk premium	5.1%
Cost of Equity	8.7%
Cost of Debt	8.6%
WACC	8.5%